Brian Joseph Cahill - 05 Jan 2024 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Signature
/s/ Brian Cahill
Issuer symbol
EGRX
Transactions as of
05 Jan 2024
Net transactions value
-$3,771
Form type
4
Filing time
09 Jan 2024, 17:01:14 UTC
Previous filing
20 Dec 2023
Next filing
06 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $3,771 -735 -1.6% $5.13 46,681 05 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of time-based restricted stock units previously granted and does not represent a discretionary transaction by the Reporting Person.